More on JAZZ
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $240.74 |
|
|||
| Open | $240.87 | ||||
| 52 Wk High | $160.00 | ||||
| 52 Wk Low | $95.80 | ||||
| Day High | $244.49 | ||||
| Day Low | $238.53 | ||||
| P/E | 44.88 | ||||
| EPS | $5.38 | ||||
| Volume | 499,163 | ||||
- UBS says this pharma name offers a robust case for stock outperformance
- Form 8-K Jazz Pharmaceuticals For: Sep 15
- Jazz Pharmaceuticals acquires Actio Biosciences for $820 million
- Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences
- Form 4 Jazz Pharmaceuticals For: Sep 10 Filed by: Patil Neena M
- Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera
- Form 4 Jazz Pharmaceuticals For: Sep 08 Filed by: GALA RENEE D
- Form 4 Jazz Pharmaceuticals For: Sep 08 Filed by: Henderson Mary Elizabeth
- Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
- Jazz Pharmaceuticals (JAZZ) PT Raised to $271 at Barclays
Entities mentioned with JAZZ
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
